StonvexLoading…
StonvexStonvexStonvexCore line items from RNG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.52B | $2.40B | $2.20B | $1.99B |
Operating Income | $120.55M | $2.67M | $-198.81M | $-649.48M |
Net Income | $43.39M | $-58.29M | $-165.24M | $-879.17M |
EPS (Diluted) | $0.48 | $-0.63 | $-1.74 | $-9.23 |
Total Assets | $1.48B | $1.78B | $1.94B | $2.07B |
Total Liabilities | $1.87B | $2.13B | $2.25B | $2.36B |
Cash & Equivalents | $132.56M | $242.81M | $222.19M | $269.98M |
Free Cash Flow OCF − CapEx | $587.32M | $458.28M | $376.15M | $158.59M |
Shares Outstanding | 91.21M | 92.11M | 94.91M | 95.24M |